CD38 and pulmonary arterial hypertension: CD38 has emerged as a promising therapeutic target for cardio-protection as it has been implicated in the pathogenesis of several cardiovascular diseases including ischemia-reperfusion injury, atherosclerosis, cardiac arrhythmias, myocardial hypertrophy and pulmonary hypertension [53].